BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 131499)

  • 1. Comparison of the bronchodilating effects of SCH 1000 with isoproterenol in patients with bronchial asthma.
    Vlagopoulos T; Townley RG; Ghazanshahi S; Bewtra A; Burke K
    Ann Allergy; 1976 Apr; 36(4):223-30. PubMed ID: 131499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerosol Sch 1000. An anticholinergic bronchodilator.
    Storms WW; DoPico GA; Reed CE
    Am Rev Respir Dis; 1975 Apr; 111(4):419-22. PubMed ID: 123712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sch 1000: a new anticholinergic bronchodilator.
    Gross MJ
    Am Rev Respir Dis; 1975 Dec; 112(6):823-8. PubMed ID: 128306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease.
    Chhabra SK; Bhatnagar S
    Indian J Chest Dis Allied Sci; 2002; 44(2):91-7. PubMed ID: 12026258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchodilating drugs and airway reactivity.
    Guerrin F; Robin H; Lahoutte C; Voisin C
    Eur J Respir Dis Suppl; 1980; 106():71-5. PubMed ID: 6110561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchodilatory and circulatory effects of inhaling increasing doses of an anti-cholinergic drug, ipratropium bromide (SCH 1000).
    Simonsson BG; Jonson B; Ström B
    Scand J Respir Dis; 1975 Sep; 56(3):138-49. PubMed ID: 1162305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successive effects of a vagolitic and a betadrenergic in the differential diagnosis of nonimmunologic and allergic asthma.
    Mathov E; Jares DM
    Allergol Immunopathol (Madr); 1984; 12(4):293-302. PubMed ID: 6239524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchodilator action of the anticholinergic drug, ipratropium bromide (Sch 1000), as an aerosol in chronic bronchitis and asthma.
    Baigelman W; Chodosh S
    Chest; 1977 Mar; 71(3):324-8. PubMed ID: 138578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Broncho-dilating effects of SCH 1000 in patients with spasmodic chronic bronchitis].
    Weitzenblum E; Rasaholinjanahary J
    Poumon Coeur; 1977; 33(4):219-24. PubMed ID: 144268
    [No Abstract]   [Full Text] [Related]  

  • 10. A new parasympatholytic bronchodilator: a study of its onset of effect after inhalation.
    Emirgil C; Dwyer K; Baskette P; Sobol BJ
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):215-24. PubMed ID: 805016
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical pharmacology of a combination of bronchodilators.
    Casali L; Grassi C; Rampulla C; Rossi A
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):277-80. PubMed ID: 157338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy with ipratropium and theophylline in asthma.
    Kreisman H; Cohen C; Ghezzo H; Vickerson F; Frank H; Wolkove N
    Ann Allergy; 1984 Feb; 52(2):90-3. PubMed ID: 6230034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ipratropium bromide in bronchial asthma.
    Taskar V; Mirchandani L; Mahashur AA; Sharma RR; Kolhatkar VP
    J Postgrad Med; 1992; 38(3):124-6. PubMed ID: 1303412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of sch 1000 metered dose aerosol, in patients with bronchial asthma and chronic bronchitis (author's transl)].
    Yernault JC; Dejonghe M; Denaut M; Englert M; de Coster A
    Acta Tuberc Pneumol Belg; 1975; 66(4-5):421-8. PubMed ID: 131479
    [No Abstract]   [Full Text] [Related]  

  • 15. [An analysis of the atrovent bronchodilator tests in bronchial asthma patients].
    Vŭlcheva T
    Vutr Boles; 1990; 29(4):92-5. PubMed ID: 2149229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the bronchodilating activity and the tolerability of broxaterol administered as a solution by inhalation.
    Ferrari M; Olivieri M; Biasin C; Pisati R; Lodola E; Lo Cascio V
    Arzneimittelforschung; 1993 May; 43(5):553-8. PubMed ID: 8101082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma.
    Hanania NA; Moore RH; Zimmerman JL; Miller CT; Bag R; Sharafkhaneh A; Dickey BF
    Respir Med; 2007 May; 101(5):1007-14. PubMed ID: 17052901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ipratropium bromide (Atrovent) in childhood asthma: a cumulative dose-response study.
    Friberg S; Graff-Lonnevig V
    Ann Allergy; 1989 Feb; 62(2):131-4. PubMed ID: 2521989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of albuterol and isoproterenol aerosols in bronchial asthma.
    Jenkinson SG; Light RW; George RB
    Ann Allergy; 1977 Dec; 39(6):423-5. PubMed ID: 339788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of ipratropium bromide in the recovery phase of methacholine induced-bronchospasm.
    Sposato B; Mariotta S; Ricci A; Bruno P; Terzano C; Mannino F
    Eur Rev Med Pharmacol Sci; 2005; 9(2):117-23. PubMed ID: 15945501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.